Anti-atherosclerotic plants which modulate the phenotype of vascular smooth muscle cells

Tuqa Saleh Al-Shehabi1, Rabah Iratni2, Ali H Eid3

  • 1Department of Health Sciences, College of Arts and Sciences, Qatar University, Doha, Qatar.

Insights

Atherosclerosis, a major cause of cardiovascular disease (CVD) death, involves vascular smooth muscle cell changes. This review explores herbs that may inhibit these cell switches, offering potential new treatments for atherosclerosis.

Area of Science:

  • Cardiovascular Research
  • Vascular Biology
  • Pharmacology

Background:

  • Cardiovascular disease (CVD) is the leading global cause of death, with atherosclerosis as a primary driver.
  • Vascular smooth muscle cell (VSMC) phenotype switching is crucial in atherosclerotic lesion development and progression.
  • Pathophysiological conditions induce VSMC transition to a synthetic phenotype with high proliferative and migratory capacities.

Purpose of the Study:

  • To review the pathogenesis of atherosclerosis, focusing on the role of VSMC phenotypic switching.
  • To explore the potential of herbal medicines in managing atherosclerosis, particularly those targeting VSMC phenotype modulation.
  • To highlight plants that inhibit the VSMC phenotypic switch as a therapeutic strategy for atherosclerosis.

Main Methods:

  • Literature review of atherosclerosis pathogenesis and VSMC biology.
  • Systematic search for studies on herbal medicine and cardiovascular disease.
  • Analysis of plant-based interventions affecting VSMC phenotype.

Main Results:

  • Vascular smooth muscle cells play a pivotal role in atherosclerosis through phenotypic plasticity.
  • Numerous plants demonstrate anti-atherosclerotic properties by influencing VSMC behavior.
  • Specific herbs show promise in inhibiting the detrimental VSMC phenotypic switch.

Conclusions:

  • Botanicals offer a promising avenue for atherosclerosis treatment and prevention.
  • Further clinical research is essential to validate the efficacy, toxicity, and tolerability of these herbal agents.
  • Evidence supports the investigation of plant-derived compounds for cardiovascular health.
Abstract

Related Concept Videos

Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.5K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
2.2K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.9K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
578
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.0K
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
4.7K